Adverse Side Effects of 5α-Reductase Inhibitors Therapy: Persistent Diminished Libido, Erectile Dysfunction, and Depression in a Subset of Patients

    December 2010 in “ The Journal of Sexual Medicine
    Abdulmaged M. Traish, John Hassani, André T. Guay, Michael Zitzmann, Michael Hansén
    Image of study
    TLDR Some patients taking finasteride or dutasteride may have ongoing sexual problems and depression even after stopping the medication.
    The document from 2011 reviews the adverse side effects of 5α-reductase inhibitors (5α-RIs), specifically finasteride and dutasteride, which are used to treat benign prostatic hyperplasia and androgenetic alopecia. It reports that a subset of patients experience persistent sexual dysfunction, including diminished libido and erectile dysfunction, as well as depression, which may continue even after stopping the medication. The Prostate Cancer Prevention Trial (PCPT) involving 18,882 men over 7 years indicated higher sexual adverse effects in the finasteride group, with 36.8% discontinuing due to side effects compared to 28.9% in the placebo group. The document stresses the need for patient awareness of these risks before starting therapy and suggests that further research is required to understand the prolonged effects in some patients. It advises extreme caution in prescribing 5α-RIs and underscores the importance of patient education regarding the potential for serious and persistent adverse effects.
    Discuss this study in the Community →

    Research cited in this study

    26 / 26 results

    Related Community Posts Join

    6 / 91 results

      community 1 month of using fin, so happy

      in Progress Pictures  859 upvotes 3 months ago
      User had a hair transplant and used a finasteride and minoxidil spray for 6 months with no results. After adding finasteride tablets for 1 month, they saw significant hair growth improvement.
      FCE 28260: A Forgotten 5α-Reductase Inhibitor

      community FCE 28260: A Forgotten 5α-Reductase Inhibitor

      in Research  330 upvotes 3 months ago
      FCE 28260 (PNU 156765), an under-explored 5α-reductase inhibitor, showcases promising results in research by Giudici et al., outperforming well-known treatments like Finasteride in reducing the conversion of testosterone to DHT. Its superior efficacy, demonstrated through lower IC50 values in both natural and human recombinant enzyme studies, suggests it could offer more effective management of DHT-related conditions. Additionally, its lower molecular weight hints at better potential for topical application, potentially offering advantages in treating conditions such as androgenic alopecia. Despite its potential, it has not advanced in development, possibly due to financial limitations, leaving its therapeutic prospects and side effect profile largely unexplored.

      community Hair Loss Drugs Ranked in Order of Efficacy

      in Research/Science  67 upvotes 11 months ago
      Dutasteride is likely the most effective treatment for male pattern baldness, followed by finasteride and minoxidil in various forms and dosages. Users discuss personal experiences, dosages, and potential side effects, with some considering combining treatments for better results.

      community Another clueless guy fearmongering and spreading misinformation

      in Chat  251 upvotes 9 months ago
      The conversation discusses hair loss treatments, with some users advocating for finasteride and minoxidil, while others express concerns about potential side effects of finasteride. A social media influencer is criticized for promoting scalp massages and minoxidil over finasteride, which some believe is misinformation.

    Related Research

    4 / 4 results